GENINUS Inc. (KOSDAQ:389030)
South Korea · Delayed Price · Currency is KRW 1,368.00
+9.00 (0.66%)
At close: Nov 13, 2026
GENINUS Market Cap
GENINUS has a market cap or net worth of 53.89 billion as of November 13, 2026. It is the 31,525th most valuable company in the world and the 1,712th biggest in South Korea. Its market cap has decreased by 28.03% in one year.
Market Cap
53.89B
Enterprise Value
33.54B
Revenue
11.28B
Global Rank
Country Rank
#1,712 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since November 8, 2021, GENINUS's market cap has decreased from 145.65B to 53.89B, a decrease of -63.00%. That is a compound annual growth rate of -17.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 53.89B | -53.84% |
| Dec 30, 2025 | 116.73B | 154.55% |
| Dec 30, 2024 | 45.86B | -47.60% |
| Dec 28, 2023 | 87.52B | 25.13% |
| Dec 29, 2022 | 69.94B | -49.53% |
| Dec 30, 2021 | 138.58B | -4.85% |
| Nov 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| 3billion | 211.30B |
| Dx & Vx | 204.24B |
| GC Medical Science | 69.37B |
| Inventera | 60.57B |
| Cytogen | 53.65B |
| Protia | 53.23B |
| HLB Panagene | 48.17B |
| Seoulin Bioscience | 29.06B |